Lurbinectedin is a chemotherapy drug that is used to treat certain types of cancer, such as small cell lung cancer. The drug works by interfering with the DNA of cancer cells, preventing them from dividing and growing.

There is no information available on the use of lurbinectedin in infants. The drug is currently only approved for use in adults, and its safety and effectiveness in children have not been established.

According to the Mayo Clinic, the use of lurbinectedin can cause a number of side effects, including nausea, vomiting, fatigue, loss of appetite, and low white blood cell count. These side effects can be severe and may require medical attention.

It is important to note that lurbinectedin is a prescription drug and should only be used under the guidance of a healthcare professional. Patients and caregivers should discuss the risks and benefits of the drug with their doctor before starting treatment.

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/LURBINECTEDIN
[2] https://www.mayoclinic.org/drugs-supplements/lurbinectedin-intravenous-route/side-effects/drg-20490804?p=1
[3] https://www.fda.gov/media/105933/download